Concepedia
Statistics
Publications
24
Citations
2.5K
H-Index
22
Active since
2007
Affiliations
Center for Drug Evaluation and Research(Current)
United States Food and Drug Administration
Center for Biologics Evaluation and Research
Amy E. McKee is an author at Center for Drug Evaluation and Research specializing in cancer research, oncology, and medicine.
Top concepts
MedicineOncologyPharmacologyCancer ResearchCancer TherapyClinical TrialsPharmacotherapyPre-clinical PharmacologyTumor BiologyRadiation Oncology
Publications per year
2007–2019
FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non-Small Cell Lung Cancer: First-Line Therapy and Beyond
Lee H. Pai-Scherf, Gideon M. Blumenthal, Hongshan Li et al. · The Oncologist · 2017 · 286 citations · Full text
FDA Approval Summary: Pembrolizumab for Recurrent Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing PD-L1
Lola A. Fashoyin‐Aje, Martha Donoghue, Huanyu Chen et al. · The Oncologist · 2018 · 224 citations · Full text
FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-cell Lymphoma
Najat Bouchkouj, Yvette L. Kasamon, R. Angelo de Claro et al. · Clinical Cancer Research · 2018 · 220 citations
FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non-Small Cell Lung Cancers Harboring <i>BRAF V600E</i> Mutations
Lauretta Odogwu, Luckson Mathieu, Gideon M. Blumenthal et al. · The Oncologist · 2018 · 212 citations · Full text
FDA Approval Summary: Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Disease Progression on or After Platinum-Containing Chemotherapy
Erin Larkins, Gideon M. Blumenthal, Weishi Yuan et al. · The Oncologist · 2017 · 210 citations · Full text
1–5 of 24